Company / Income Tax
Barinthus Biotherapeutics plc. Income Tax History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$175.0K
FY2025
5-year range
-$4.5M / $95.0K
FY2021-FY2025
Trend
+94.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from -$4M to -$175,000 over the past 2 years.
Based on SEC 10-K filings.
-$175,000 in FY2025.
Increased from -$4M to -$175,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, income tax increased 94.3% year-over-year.
- Peak income tax was recorded in FY2021.
- Lowest income tax in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$175.0K | +94.3% |
| FY2024 | -$3.1M | +31.2% |
| FY2023 | -$4.5M | -15867.9% |
| FY2022 | -$28.0K | -129.5% |
| FY2021 | $95.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026